Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

5-HT4 receptor agonists emerge from Dainippon R&D

July 26, 2005

Pradefovir reduces viral load of patients with chronic hepatitis B

July 25, 2005

Therapeutic agents for hepatitis C infection claimed

July 22, 2005

InterMune and Array BioPharma expand HCV collaboration

July 22, 2005

Phase III program studies tenofovir disoproxil fumarate for chronic hepatitis B

July 22, 2005

Fast track status for XTL-6865 in prevention of posttransplant HCV reinfection

July 21, 2005

LG Life Sciences claims new agents for acute hepatitis, liver cirrhosis and rheumatoid arthritis

July 20, 2005

Good safety and pharmacokinetic profile of XP-19986 in healthy volunteers

July 20, 2005

SPA agreement for phase III study of renzapride for c-IBS

July 19, 2005

Migenix and Schering-Plough sign agreement for MX-3253

July 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...